<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Glutamin metabolizması &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/glutamin-metabolizmasi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 13:22:08 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Glutamin metabolizması &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Glutamine Boosts NPDC1, Fueling Colorectal Cancer Progression</title>
		<link>https://bioengineer.org/glutamine-boosts-npdc1-fueling-colorectal-cancer-progression/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 13:21:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cancer biomarkers** **Açıklama:** 1. **Glutamine metabolism:** Makalenin temel odağı]]></category>
		<category><![CDATA[colorectal cancer progression]]></category>
		<category><![CDATA[Glutamin metabolizması]]></category>
		<category><![CDATA[glutamin metabolizmasının kanser ilerlemesindeki rolü. 2. **NPDC1:** Araştırmanın keş]]></category>
		<category><![CDATA[İşte içerik için 5 uygun etiket: **Glutamine metabolism]]></category>
		<category><![CDATA[Kanser ilerlemesi]]></category>
		<category><![CDATA[Kolorektal Kanser]]></category>
		<category><![CDATA[NPDC1]]></category>
		<category><![CDATA[NPDC1 proteini]]></category>
		<category><![CDATA[PI3K/Akt signaling]]></category>
		<category><![CDATA[PI3K/AKT sinyal yolu]]></category>
		<guid isPermaLink="false">https://bioengineer.org/glutamine-boosts-npdc1-fueling-colorectal-cancer-progression/</guid>

					<description><![CDATA[Recent research has unveiled the pivotal role of glutamine in the progression of colorectal cancer, spotlighting its influence through the upregulation of NPDC1, a previously underexplored protein in the context of tumorigenesis. The study conducted by Qin, Zhang, and Xie et al. demonstrates how the metabolic pathways associated with glutamine can significantly alter cancer cell [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320300</post-id>	</item>
		<item>
		<title>Glutamine Boosts Gemcitabine Resistance in Pancreatic Cancer</title>
		<link>https://bioengineer.org/glutamine-boosts-gemcitabine-resistance-in-pancreatic-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 02:58:54 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[**5 uygun etiket:** Pankreas kanseri]]></category>
		<category><![CDATA[Gemcitabine direnci]]></category>
		<category><![CDATA[Gemcitabine resistance]]></category>
		<category><![CDATA[Glutamin metabolizması]]></category>
		<category><![CDATA[Glutamine Metabolism]]></category>
		<category><![CDATA[İmmün kaçış **Açıklama:** 1. **Pankreas kanseri:** Çalışmanın temel odağı pankreas kanseri olduğu için en temel etikettir. 2. **Gemcitabine direnci:** Mak]]></category>
		<category><![CDATA[immune evasion]]></category>
		<category><![CDATA[pancreatic cancer]]></category>
		<category><![CDATA[SLC6A14]]></category>
		<guid isPermaLink="false">https://bioengineer.org/glutamine-boosts-gemcitabine-resistance-in-pancreatic-cancer/</guid>

					<description><![CDATA[In an increasingly cancer-conscious world, new research findings are pointing towards a promising therapeutic strategy to tackle one of the most aggressive forms of cancer: pancreatic cancer. A collaborative study led by Kang et al. has provided groundbreaking insights into the biochemical pathways that underlie the resistance of pancreatic cancer cells to gemcitabine, a commonly [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319612</post-id>	</item>
	</channel>
</rss>
